These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19747868)

  • 1. Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes.
    MacLeod EL; Gleason ST; van Calcar SC; Ney DM
    Mol Genet Metab; 2009 Dec; 98(4):331-7. PubMed ID: 19747868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M; Truby H; Boneh A
    Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Singleton and twin pregnancies of PKU patients - individual variability of phenylalanine tolerance: experience of a single treatment center (Preliminary report)].
    Żółkowska J; Hozyasz KK; Nowacka M
    Dev Period Med; 2017; 21(4):344-360. PubMed ID: 29291362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
    Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity.
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Aug; 16(17):. PubMed ID: 39275225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of phenylalanine tolerance in pregnant phenylketonuria patients homozygous for the p.R408W mutation: the need for improved understanding of phenylalanine homeostasis.
    Hozyasz KK; Żółkowska J
    J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):491-497. PubMed ID: 30907078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BH(4) supplementation on phenylalanine tolerance.
    Burlina A; Blau N
    J Inherit Metab Dis; 2009 Feb; 32(1):40-5. PubMed ID: 19067227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis.
    Pinto A; Ilgaz F; Evans S; van Dam E; Rocha JC; Karabulut E; Hickson M; Daly A; MacDonald A
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride.
    Stockler-Ipsiroglu S; Yuskiv N; Salvarinova R; Apatean D; Ho G; Cheng B; Giezen A; Lillquist Y; Ueda K
    Mol Genet Metab; 2015 Mar; 114(3):409-14. PubMed ID: 25497838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesterol in adults with phenylketonuria.
    Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR
    Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients.
    Teruya KI; Remor E; Schwartz IVD
    Am J Med Genet A; 2021 Jul; 185(7):1991-2002. PubMed ID: 33765361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.